What does 'clipping a 12% coupon' mean in pharmaceutical stock investing?

In pharmaceutical stock investing, 'clipping a 12% coupon' refers to earning a high dividend yield from a major pharmaceutical company's stock. This typically involves investing in established 'Big Pharma' names that pay substantial dividends, often resulting from their stable revenue streams from patented drugs, mature product portfolios, and strong cash flows. A 12% yield is exceptionally high compared to the sector average, which usually ranges from 2-4%, indicating either a temporarily depressed stock price or a company with robust dividend policies. Investors 'clip the coupon' by holding the stock and receiving regular dividend payments, similar to how bondholders receive interest. This strategy is appealing for income-focused investors seeking reliable returns, especially in volatile markets, as pharmaceutical companies often have defensive characteristics due to consistent demand for healthcare products. However, such high yields may also signal market concerns about the company's growth prospects or sustainability, so thorough analysis of the company's financial health, pipeline, and dividend coverage is essential before investing.

📖 Read the full article: Clipping a 12% Coupon on a Big Pharma Name - TheStreet Pro